Yale University’s Teladoc Health TDOC Stock Holding History

Yale University’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,963	Closed	-$163K	–	11
2016 Q1	$163K	Buy	+16,963	New	+$241K	0.05%	5

Other funds holding TDOC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Yale University's TDOC Position: Q2 2016 in Review

Yale University sold out of Teladoc Health (TDOC) in Q2 2016, closing a stake of 16,963 shares — an estimated $163K sold.

Yale University first reported a position in TDOC in Q1 2016 and held it in 1 quarter. The position peaked at $163K in Q1 2016. 88 funds tracked by Wall St. Rank hold TDOC as of Q2 2016.

Yale University reported no remaining Teladoc Health position as of Q2 2016 after selling out during the quarter.
Yale University sold 16,963 Teladoc Health shares in Q2 2016, an estimated $163K.
Yale University first reported a position in Teladoc Health in Q1 2016 and held it in 1 quarter.
Yale University's Teladoc Health position peaked at $163K in Q1 2016.
88 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2016.

Based on Yale University's 13F filing for Q2 2016, filed 11 Aug 2016.